Previous 10 | Next 10 |
Spending on cancer medicines is expected to reach $375Bn globally by 2027, up from $196Bn in 2022 For approved medicines, the number of patients treated globally has increased annually by an average of 5% over the past five years Oncology trial starts remained at historically high...
2023-05-23 06:10:56 ET Summary Despite some concerns about TAS performance, overall demand remains robust. While TAS performance was weak in the first quarter, it is expected to recover in the second half of the year. IQV's valuation has fallen below its historical average, tr...
2023-05-18 17:02:53 ET IQVIA Holdings ( NYSE: IQV ) said Thursday its unit, IQVIA Inc., has priced an offering of $1.25 billion of senior notes, which was upsized from $1 billion, citing strong demand. The offering consists of $750 million of senior secured notes due 2028 and ...
IQVIA Holdings Inc. (NYSE:IQV) today announced that its wholly-owned subsidiary, IQVIA Inc. (the “Issuer”), priced an offering of $1,250,000,000 in aggregate principal amount of senior notes, which was upsized due to strong demand, consisting of $750,000,000 in aggregate principal a...
IQVIA Holdings Inc. (NYSE:IQV) today announced that its wholly-owned subsidiary, IQVIA Inc. (the “Issuer”), intends to raise $1,000,000,000 through an offering of senior secured notes due 2028 and senior notes due 2030 (collectively, the “Notes”). The proceeds from...
2023-05-15 07:15:14 ET Shares of ANI Pharmaceuticals ( NASDAQ: ANIP ) spiked in the pre-market Monday after announcing that the FDA approved the market entry of the company’s generics for seizure therapy Celontin and osteoporosis drug RLD Fosamax Oral Solution. In approvi...
IQVIA (NYSE:IQV) today announced that Sheetal Telang, vice president of Therapeutic Strategy, has been honored with the 2023 Rising Star award by the Healthcare Businesswoman's Association (HBA). Sheetal earned the award for her strong and innovative leadership, combined with her exemplary wo...
2023-05-09 15:23:46 ET The Federal Trade Commission is investigating IQVIA Holdings ( NYSE: IQV ) planned purchase of Propel Media, which owns an advertising tech company used by many drugmakers. IQVIA is paying $700M-$800M for Propel Media, which owns DeepIntent, Politico r...
2023-05-07 12:00:27 ET Patients in the U.S are expected to dish out $10B on obesity medicines in 2027, marking an $8.1B rise or over 378% growth for the period 2023 – 2027, the latest industry report on pharma spending from the drug analytics firm IQVIA Holdings ( IQV ) indicates...
2023-05-02 15:43:45 ET The U.S. Food and Drug Administration (FDA) on Tuesday issued a draft guidance to offer further support for decentralized clinical trials (DCTs) where studies for treatments and medical devices can take place beyond traditional trial sites. DCTs can lower the barr...
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 10:00:13 ET Jailendra Singh from Truist Financial issued a price target of $300.00 for IQV on 2024-07-23 09:26:00. The adjusted price target was set to $300.00. At the time of the announcement, IQV was trading at $240.265. The overall price target consensus is...
2024-07-23 10:00:11 ET Elizabeth Anderson from Evercore ISI issued a price target of $270.00 for IQV on 2024-07-23 08:59:00. The adjusted price target was set to $270.00. At the time of the announcement, IQV was trading at $239.5. The overall price target consensus is at...
2024-07-23 07:00:06 ET Luke Sergott from Barclays issued a price target of $275.00 for IQV on 2024-07-23 05:25:00. The adjusted price target was set to $275.00. At the time of the announcement, IQV was trading at $245.23. The overall price target consensus is at $273.93 ...